Suppr超能文献

原发性甲状旁腺功能亢进患者的心脏异常:对随访的意义。

Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up.

作者信息

Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B

机构信息

Department of Cardiology, University of Vinna Medical School, Austria.

出版信息

J Clin Endocrinol Metab. 1997 Jan;82(1):106-12. doi: 10.1210/jcem.82.1.3666.

Abstract

Patients with primary hyperparathyroidism (PHPT) show a high incidence of left ventricular hypertrophy, cardiac calcific deposits in the myocardium, and/or aortic and mitral valve calcification and thus may carry an increased risk of death from circulatory diseases. This prospective study was designed to assess an effect of parathyroidectomy on cardiac abnormalities of patients with PHPT. Echocardiography was used to evaluate the mechanical performance of the heart muscle, the thickness of the left ventricular wall, myocardial calcific deposits, and valvular calcifications within 12 and 41 months after parathyroidectomy. In a blinded fashion, aortic and mitral value calcifications were determined in 46% and 39% of patients with PHPT. Calcific deposits in the myocardium were found in 74% of patients. Follow-up studies after parathyroidectomy disclosed no evidence of progression of these calcifications. Before operation left ventricular hypertrophy was detected in 82%. After parathyroidectomy and 41 months of normocalcemia and normal PTH concentrations, a regression of hypertrophy of the interventricular septum and the posterior wall by -6% and -19% (P < 0.05) was observed. Subgroup analysis disclosed the most impressive long-term reduction of left ventricular hypertrophy in patients without a history of hypertension (-11% and -21%; P < 0.05 and P < 0.005); no changes were determined in 9 patients who developed secondary hyperparathyroidism after operation. The present data show a high incidence of left ventricular hypertrophy and aortic and/or mitral valve calcifications in patients with PHPT. Follow-up at 1 year and at 41 months after successful parathyroidectomy disclose regression of hypertrophy. Our results give evidence that parathyroid hormone per se plays an important role in the maintainance of myocardial hypertrophy. Post-surgical restoration of normocalcemia and normalization of parathyroid hormone valvular sclerosis persists without evidence of progression. We further conclude that patients with PHPT and parathyroidectomy are at low risk for the development of severe aortic and mitral valve stenosis within this period of time.

摘要

原发性甲状旁腺功能亢进症(PHPT)患者左心室肥厚、心肌钙化沉积以及主动脉和二尖瓣钙化的发生率较高,因此循环系统疾病导致的死亡风险可能增加。这项前瞻性研究旨在评估甲状旁腺切除术对PHPT患者心脏异常的影响。在甲状旁腺切除术后12个月和41个月内,采用超声心动图评估心肌的机械性能、左心室壁厚度、心肌钙化沉积和瓣膜钙化情况。以盲法确定,46%的PHPT患者存在主动脉瓣钙化,39%的患者存在二尖瓣钙化。74%的患者心肌有钙化沉积。甲状旁腺切除术后的随访研究未发现这些钙化有进展的迹象。术前82%的患者检测到左心室肥厚。甲状旁腺切除术后,在血钙正常和甲状旁腺激素(PTH)浓度正常41个月后,观察到室间隔和后壁肥厚分别消退了6%和19%(P<0.05)。亚组分析显示,无高血压病史的患者左心室肥厚的长期减轻最为显著(分别为11%和21%;P<0.05和P<0.005);9例术后发生继发性甲状旁腺功能亢进的患者未发现变化。目前的数据显示,PHPT患者左心室肥厚以及主动脉瓣和/或二尖瓣钙化的发生率较高。成功进行甲状旁腺切除术后1年和41个月的随访显示肥厚有所消退。我们的结果表明,甲状旁腺激素本身在维持心肌肥厚中起重要作用。术后血钙恢复正常且甲状旁腺激素正常化后,瓣膜硬化持续存在且无进展迹象。我们进一步得出结论,在此时间段内,接受甲状旁腺切除术的PHPT患者发生严重主动脉瓣和二尖瓣狭窄的风险较低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验